Dan Anderson, Ph.D.
Dr. Anderson has spent the last 10 years developing non-viral gene delivery agents. These studies have resulted in delivery materials with excellent gene delivery performance in vitro and in vivo. Products based on these materials have been commercialized specifically to transfect stem cells (Stemfect from Stemgent, Xfect from Clonetech). He has also spent significant effort towards the in vivo application of DNA and RNA delivery systems, and have demonstrated delivery efficacy in a variety of species, including primates.
Page last updated: August 31, 2016